Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
Roland Griffiths, an internationally revered researcher of psychedelic and mood-altering drugs, whose research helped kickstart a new era of psychedelic study and led to the creation of the nation’s first psychedelic research center, at Johns Hopkins, died on Monday, Oct. 16, 2023, at age 77.
Griffiths’ work generated immense scientific and philanthropic interest, including $17 million in gifts that led to the creation of the Center for Psychedelic and Consciousness Research in 2019, where he served as the founding director. He was diagnosed with colon cancer in November 2021.
- 70 views
